How Our Hero Products Improve Quality Of Life For Patients

How Our Hero Products Improve Quality Of Life For Patients

At Meril Life Sciences we strive to improve the quality of human lives by manufacturing innovative solutions that empower healthcare professionals and the medical fraternity. Our manufacturing facilities adhere to cGMP guidelines, are ISO 13845:2003 certified and DCG (I)-approved. Over the years, we have created over 140 products that adhere to the highest possible standards of quality and innovations spread across 5 divisions and are available in more than 100 countries. At Meril, our continual goal is to identify unmet clinical needs and churn out relevant devices in quick turnaround cycles. We strive to be trendsetters in new product introductions. That’s where our dedicated R&D facility comes in, which hosts more than 150 R&D personnel, working in cross functional capacities. These innovators are tasked with creating top of the line products that adhere to each and every safety guideline while still pushing the envelope by creating healthcare solutions that are effective. To understand how this happens let us take a look at some of our hero products from different divisions and see for ourselves just how much effort goes into each and every single one of our products.

BioMime

Beginning with a medical device that is at the forefront of cardiovascular intervention, we have the BioMime. The BioMime is a Sirolimus Eluting Coronary Stent System with an ultra-thin (65 µm) strut thickness. It is a next-generation SES with a novel & hybrid design consisting of both closed and open cells. It is made from a Biodegradable Polymer with 2µm low thickness which helps facilitate faster healing. The anatomy of a strut in medical devices such as BioMime is a crucial factor in determining how well it can help patients. The strut width variability of the BioMime allows for optimal radial strength & conformability. The BioMime is an assured step towards biomimicry.

Opulent knee

With the help of world-renowned surgeons and a large range of orthopedic devices, Meril Life Sciences has emerged as a frontrunner in the field of orthopedics. The opulent knee is a knee replacement device that revolutionised this industry. For more than 50 years now, cobalt chrome was used to create knee implants. However, to stimulate better performance and patient outcomes, we at Meril Life Sciences made use of a Titanium niobium nitride (TiNbN) coating which is 40% less likely to be worn down than regular cobalt chrome implants. The opulent knee is twice as strong as similar implants in the category; the most biocompatible and non-allergic surface material out there and 8 times harder. With so many positive points working in its favour, the opulent knee system has earned its place as the ideal implant for young and old patients who want to enjoy active, long-term and high-quality performance and provide them with a lasting knee pain remedy.

Mitsu

Meril endosurgery is a one-stop solution for surgeons, providing them with an extensive product portfolio to rely on. Any form of minimally invasive surgery in which a small video endoscope is inserted into the body can be classified as endosurgery. Commonly performed endosurgery procedures include appendectomies, bowel resections, gallbladder surgeries, hernia repairs, splenectomies, and cancer staging operations. Endosurgery does not require a major incision. Small incisions are made in the body through which a flexible endoscope can be inserted allowing internal imaging to be projected. This allows for a robotic procedure which eliminates unwanted motion and improves surgical dexterity. This method allows remote surgery to be performed by skilled surgeons who approach each operation with precision and focus. Meril endosurgery product Mitsu, is a mid-term absorbable braided and coated synthetic suture made of polyglactin. The Mitsu is an absorbable surgical suture with excellent advantages such as gentle knot repositioning, excellent knot security, smooth knot rundown and excellent pliable material that allows for easy handling. Especially Mitsu AB which helps in Antibacterial wound closure and helps in preventing surgical site infection which is very important to take care after any surgery as patients wants to escape and avoid such situation. As a surgical suture, Mitsu degrades by hydrolysis and assures predictable and reliable absorption. It is a testament to just how essential and beneficial surgical sutures can be.

Read more at https://www.merillife.com/blog/medtech/how-our-hero-products-improve-quality-of-life-for-patients

TAVR: A powerful ally in the battle against Aortic Valve Stenosis

TAVR: A powerful ally in the battle against Aortic Valve Stenosis

The Meril Life in the news section exists to look at the current state of the healthcare industry, the world at large and our impact on the world. From headlines that make India proud to informing readers about the precautions that should be taken to deal with the CoronaVirus pandemic. The ‘in the news’ section is our way of giving back to the world. Meril Life continues to make headlines for their contributions to Medtech, creating products which reduce discomfort for patients headlines that make our country proud. While we are always glad to be making a global change that helps everyone, sometimes it can be as simple as helping an individual. After all, it is only when we are able to help make an individual’s life easier that we will be able to make an impact on every single human life. So, today we would like to share some light on one individual case that was recently covered by the American news outlet – KTBS-TV. Today, we would like you to meet Wanda Lyons and how TAVR technology changed her life for the better.

The patient

Wanda Lyons’ was born with a congenital heart defect. In her old age, she knew that she was at risk of requiring a severe heart procedure. Being a retired nurse herself, Wanda was no stranger to hospitals and open heart surgeries. She began to notice that she was losing her stamina too quickly and required stopping two or three times just to tend to her garden. Being well-versed in the symptoms of coronary artery disease, she decided to visit the hospital where she used to work for a check-up. Looking at her case, the cardiologist at ACS general hospital, Dr. Rodney Reeves, considered the TAVR. procedure as the preferred method of treating Wanda Lyons.

The procedure

TAVR is an acronym for a transcatheter aortic valve replacement procedure. It is an alternative treatment method to open-heart surgery where a fully collapsible valve is placed directly into the heart valve through a catheter. Being a therapy that had been approved merely 6 months prior, Lyons had her doubts. However, Lyons could not hide her own surprise at just how quick, easy and helpful the procedure was. The procedure took place through a tiny puncture in her leg. It was done in a total of three hours and by the same evening; Lyons was healthy enough to be walking around the nurse’s station to meet with new and old colleagues alike. In less than a week, Lyons was free to leave the hospital and enjoy her new lease on life.

Benefits of TAVR

Based on the 30-day primary outcome data, these are the observable benefits of using Myval in patients.

  • Lowers incidences of stroke
  • Lowers device-related mortality
  • Lowers the need for a pacemaker
  • 97% device success rate displayed during the 30-day trial
  • Cobalt alloy frame for high radial strength and radiopacity
  • Lowers the risk of myocardial infarction
  • Lowers risk of major and minor vascular complications

TAVR technology

Myval Transcatheter aortic valve replacement (TAVR) system is a minimally invasive procedure to replace the aortic valve in patients with severe aortic valve stenosis or heart murmur. TAVR and TAVI are both terms used to describe the same procedure. Valve replacement procedures generally require an open-heart procedure with a “sternotomy”, in which the chest is surgically opened. The TAVR or TAVI procedures on the other hand require very small openings that leave all the chest bones in place. While TAVR is not without risks, it provides treatment options to people who may not be considered for an open heart procedure. In some instances, the TAVR procedure can take place without general anesthesia and without stopping the heart. The benefits of opting for TAVR include reduced pain & anxiety, improved heart function, shorter hospital stay, faster recovery times and a better quality of life. These are just a few of the reasons why TAVR technology is becoming so popular in recent years.

The doctor and patient understand the conditions and then determine whether open-chest surgical aortic valve replacement (SAVR) or minimally invasive transcatheter aortic valve replacement (TAVR) is the better option, taking into consideration a wide range of factors, including the patient’s own preferences. The TAVR procedure may relieve signs and symptoms of aortic valve stenosis and improve your overall health and quality of life. It is one of the several innovations and medical devices that Meril Life Science has on their side when faced with the daunting mission of providing better healthcare solutions and medical devices to the world. Wanda Lyons is just another example of the fact that we are heading in the right direction towards meeting that goal.

Read more at https://www.merillife.com/blog/in-the-news/tavr-a-powerful-ally-in-the-battle-against-aortic-valve-stenosis

What is TAVR?

What is TAVR?

TAVR stands for Transcatheter Aortic Valve Replacement. Unless you are a trained healthcare professional, just the name might not be enough to explain its purpose. The Myval TAVR procedure is an indigenously developed minimally invasive procedure used to combat aortic stenosis and other coronary artery diseases. Many healthcare professionals predict that TAVR therapy might potentially replace open-heart surgeries someday as the most favoured treatment of heart surgery. We have already spoken about how this technology helped save the life of an 83-year-old woman, now let us take a look at what this technology is and just why it is making such waves in the Medtech industry.

Understanding TAVR

The TAVR procedure is a minimally invasive method that involves placing a new valve over the patient’s diseased heart valve via a catheter. This catheter is inserted through the femoral artery or small incisions made in the body. Similar to placing a stent in an artery, TAVR system delivers a fully collapsible replacement valve into the affected heart valve through a catheter. The newly placed valve is expanded with the help of balloon technology, which pushes the old valve leaflets out of the way.  The tissue present in the replacement valve takes over the job of regulating blood flow in the heart. This leads to minimal scarring in patients and quicker recovery times post-procedure. It is an FDA approved procedure recommended to high-risk patients with aortic stenosis. While the TAVR procedure is not completely risk-free, it does provide a safer alternative to people who may not be viable candidates for open-heart surgery. Treating aortic stenosis with TAVR procedure can only be made after you consult with your general physician and a team of heart specialists and heart surgery specialists. These doctors work together to understand your medical history, the risk factors involved and help determine the best treatment option for you. This procedure helps relieve the signs and symptoms of aortic valve stenosis and can also greatly improve the chance of survival in people who are displaying severe symptoms.

Benefits of TAVR

Based on the 30-day primary outcome data, these are the observable benefits of using Myval in patients.

  • 97% device success rate displayed during the 30-day trial
  • Lowers incidences of stroke
  • Lowers device-related mortality
  • Lowers the need for a pacemaker
  • Cobalt alloy frame for high radial strength and radiopacity
  • Lowers risk of major and minor vascular complications

What is involved in a TAVR procedure?

A valve replacement procedure generally requires an open-heart procedure with a “sternotomy”, in which the chest is surgically separated (opened) for the procedure. The TAVR or TAVI procedures can be done through very small openings that leave all the chest bones in place. Undergoing a TAVR procedure typically takes approximately 1-2 hours. At the beginning of the procedure, you will be given a mild sedative or general anesthetic. A thin flexible tube containing the heart valve will then be guided through the femoral artery or a small incision into the patient. With the help of the catheter, which is a specialised hollow tube and advanced imaging tools, the valve is placed in the affected area of the heart. Once the valve is in position, the balloon is expanded to place the new valve into the diseased valve. The TAVR heart valve will begin treating the valve immediately and the doctor will then remove the tube and close the incision.

Who should opt for this procedure?

The TAVR procedure cannot simply be defined as a low-risk procedure. It is a procedure that is available to patients in all risk categories. It serves as an effective option to improve quality of life in patients who otherwise have limited choices for repair of their aortic valve. Average recovery time after this procedure is a period of 3-5 days. Being a non-surgical technology that leaves no scars, reduces anxiety, shows improved signs of heart functions with a short hospital stay, it is definitely a procedure that people are discussing. This procedure used to be reserved only for people too weak to undergo open-heart surgery. But now, any severe aortic stenosis patient may consider TAVR as a viable option. Your treatment team will give you instructions on how to prepare for your transcatheter aortic valve replacement (TAVR) procedure. Talk to your doctor if you have any questions about the procedure.

 Myval Transcatheter Heart Valve system

Up until now we have discussed what TAVR is, how it functions and the benefits of TAVR therapy. Let’s understand Myval Transcatheter Heart Valve System, indigenously designed and developed by Meril Life Science in various optimal sizes. Myval has a hybrid design with unique appearance of alternating light and dark bands under fluorescence, supporting ease of positioning on the annular plane. Its unique crimping pattern ensures precise orthotopic device placement without any deep throating into the LVOT. Precise annular placement ensures that there are no conduction system disturbances thus eliminating the need for a new pacemaker as seen with previous technologies. Myval comes with a navigator balloon with a dual-stopper system for precision in positioning & deployment.

The Myval TAVR system is a CE approved medical device and has been clinically evaluated with high safety and efficacy standards. The Myval-1 study presented at EuroPCR 2019 shows that the TAVR procedure has shown promising patient outcomes and high-procedural success over a period of 30 days, 6 months and 1 year. The success of the Myval TAVR system is just another step in our ultimate goal of creating better patient outcomes and improving quality of life. TAVR was the first to provide a treatment option for people who cannot undergo surgery to replace narrowed valves, where none existed before. It also presents patients with a minimally invasive alternative. We are now investigating its possible use in an even wider range of people.

Read more at https://www.merillife.com/blog/medtech/what-is-tavr

The Use Of Robots In The Field Of Orthopedics

The Use Of Robots In The Field Of Orthopedics

Meril Life Sciences Pvt Ltd. is dedicated to innovation and staying up-to-date with the latest medical devices and advances in healthcare technology. Based on a report by Credence Research, the global medical robotics market was valued at $7.24 billion in 2015 and is expected to grow to $20 billion by 2023. These robots are being created to fit a wide variety of roles within the medical environment. These include robots that provide therapeutic, surgical and even industrial assistance in the creation of medical devices that deliver flawless results.

In the current scenario, where safety and sterility in preparation and delivery of medical supplies and equipment is a paramount concern, robots are the way that leads to the future of health and medtech. To combat these healthcare concerns, Meril Life Sciences is proud to be one of the few companies in India relying on the use of robots to continue delivering the cutting edge in healthcare technology. Here are some ways in which Meril life Sciences Pvt Ltd. makes use of robots to deliver the highest quality possible.

Femur finishing with robot

The Femur or the thigh bone is the longest and strongest bone in the human body. In the field of orthopedics, the use of robots allows for extremely high precision. These robots are also 2.5 min/piece rate faster than their human counterparts. The unmatchable precision in surface finishing results in a 40% reduction in rework requirements. At the same time, robots do not create any sound or air pollution or waste which makes them the ideal workers. These robots are monitored by experts in the field to ensure that they are fulfilling their roles and following the correct processes.

Quality control by robot

An orthopedic implant such as a knee replacement device is one that patients need to spend years with. When it comes to implants created for the purpose of improving human life, there should be no scope for errors. To ensure this we employ a 100% implant check by robots instead of batch sampling the products. At Meril Life Sciences Pvt. Ltd, we ensure 0% quality negligence with the help of robot-assisted quality checks and control with better accuracy of 0.2 micron and a 30% faster check than widely used conventional instruments. Robotic systems can be classified into two categories: autonomous and haptic (or surgeon-guided). Passive surgery systems, which represent a third type of technology, have also been adopted recently by orthopaedic surgeons. All three of these systems have been proven to increase the accuracy of the alignment of the components and produce more consistent ligament balance. Which makes the use of robots in orthopedics manufacturing a safe and reliable quality control method.

How the introduction of robots affects us

We have already gotten used to the machines that monitor a patient’s vitals and alert nurses when there is a need for human presence in the room. Such technology is what allows nurses and hospitals to be able to monitor several patients at once. Robots can also be helpful in moving medical supplies from one place to another. Robotic and mechanical technologies are already in use in many different areas of our life which directly affect and aid patient care. Robots can be used to disinfect patient rooms and operating suites, reducing risks for patients and healthcare professionals. The biggest question that most people have when it comes to the introduction of robots in the field of medicine is ‘whether these robots will take jobs away from humans.’ The simple answer is no. Two of the most important reasons are that for one it is simply too expensive. Robots need to be programmed to carry out their job down to every last command. They also require regular upkeep and maintenance which drives up costs. The second and most important reason that this won’t happen is because robots cannot replace or replicate basic human contact. When a person is sick or in danger there is a requirement to remind him or her that it will all be better. This emotional support cannot be provided by a robot as robots simply follow instructions.

At Meril Life Sciences Pvt Ltd. we are committed to delivering the absolute best in quality to our patients, doctors and shareholders every time. The use of robots in orthopedic procedures such as a hip replacement surgery allows for high precision and quality implants. Robot-assisted orthopaedic surgery has the potential for improving surgical outcomes. This high quality can accurately be replicated to cater to a large variety of products. As a result, a wide range of robots are being developed to serve in a variety of roles within the medical environment. The use of robotics in the field of medicine with supervision from leaders is the sustainable solution to creating a future made of accurate and best-in-class instruments.

Read more at https://www.merillife.com/blog/innovations/the-use-of-robots-in-the-field-of-orthopedics

The Opulent Bionik Gold Knee: The Cutting Edge in Knee Replacement Technology

The Opulent Bionik Gold Knee: The Cutting Edge in Knee Replacement Technology

The knee joint is one of the strongest joints in our body. The knee joint allows the lower leg to move relative to the thigh while supporting the body’s weight. The knee joint is essential to many everyday activities, including walking, running, sitting and standing. The knee, which is also known as the tibiofemoral joint, is a synovial joint made up of three bones: the femur, tibia, and patella. Being an integral part of everyday activity, our knees often undergo a lot of stress, thus making it susceptible to injuries, knee pain and ailments such as arthritis. Meril orthopedics is the division dedicated solely to orthopedic complications. To combat complications in the knee, Meril has created the opulent knee system to restore the ability to resume normal activity in old and young patients.

What is Knee Replacement?

The knee is made up of the lower end of the thigh bone known as the femur, the upper end of the shin bone which is known as the tibia and the kneecap which is known as the patella. The first knee replacement surgery was performed in 1968 as a treatment method for knee pain which would be more effective for patients that were still facing issues after regular medication. A knee replacement operation, also known as a knee arthroplasty replaces the surface of the knee. Such a procedure might be recommended to a patient if the patient is undergoing severe pain in the knee that restricts their everyday activities, an abnormal bending of the legs or a chronic redness in the knee that is not relieved after medicines. The decision to undergo total knee replacement surgery is a decision that should be cooperatively between you, your family, your physician and your orthopaedic surgeon. To reduce complications and worries for patients and doctors alike when it comes to knee replacement surgeries, Meril Life Sciences created the Opulent Bionik Gold knee technology.

 Why Choose Opulent Bionik Gold Knee

The Opulent Bionik Gold Knee is a medical device that builds on the base science, successes and learnings gained from the Freedom Knee system. The Freedom Knee System was a highly effective, safe and predictable knee replacement procedure. The Freedom Total Knee system had proved to be an effective treatment method for osteoarthritis for a minimum of 3 years post-procedure. The Opulent Bionik Gold Knee builds on this base set by The Freedom Total Knee and replaces its Cobalt Chromium(CoCr) coating and replaces it with a Titanium niobium nitride (TiNbN) coating which is 8 times harder than a regular cobalt chromium product. The Opulent Bionik Gold Knee improves on everything that came before it. It is twice as hard as the Zirconium Oxide implants currently being used in similar products. The Opulent Bionik Gold Knee is currently the most biocompatible non-allergic surface material out there, with a mere 0.0008 times ionic release compared to that of regular Cobalt Chromium products. Friction in the knee caused by the implant is also less than half when compared to its predecessor. Further benefits of the Opulent knee have been listed below.

 

Decrypting Covid19: All We Know About the Novel Coronavirus so far.

Decrypting Covid19:  All We Know About the Novel Coronavirus so far.

What started off as a virus contained to one country has today become a concern for the whole world. Today, doctors, researchers and other healthcare workers are relentlessly pursuing every effort to curb the spread of Covid-19 in whichever way they can.

As time passes, we have found out a few characteristic traits of the novel coronavirus, and this is helping us trace and deal with the disease in a much better way. In a recently held session by by  Dr. Manuj Wadhwa, Chairman and ED at Ivy Elite Institute of Orthopedics & Joint Replacement, he spoke about the various ways through which doctors can identity the disease. While doctors are obviously following these protocols, it is good for everyone to know the basics of the disease to help steer clear of it in the near future.

What is it that makes Covid-19 a ‘novel’ disease?
The term ‘coronavirus’ as a whole refers to a family of various pathogens that can cause illness ranging from the common cold to more severe diseases. When a new strain that has previously not been identified in humans appears, it becomes known as a ‘Novel’ Coronavirus (nCOV). The strain that has now been named Covid-19 is unique in nature. Structurally, it comprises of a nucleoprotein at its center, which is surrounded by a layer of fat that has protein crowns on it. Genetically, it is related to the SARS virus that occurred in 2003, but both the diseases are unique in their own ways.

Washing Your Hands Off It
As we mentioned earlier, the virus is surrounded by a layer of fat that keeps it protected. When you wash your hands vigorously with soap for 20 seconds, the fat layer starts to crack and thus, the virus has no chances of surviving on your hands.

The Spread Pattern – Factors & Facts
By now, we all know that Covid-19 spreads because of coughing and sneezing. And that begets the question – is the disease airborne? Well, thankfully the virus can ONLY be spread by a human carrier. The virus that causes COVID-19 is mainly transmitted through droplets generated when an infected person coughs, sneezes, or speaks. These droplets are too heavy to hang in the air. They quickly fall on floors or surfaces.

Now, because of their particular composition, they can live on these surfaces for a few hours or for a couple of days. The surface material, temperature and humidity are factors that come into play here. One thing that has been confirmed by doctors is that, contradictory to earlier opinion, Covid-19 does survive in temperatures over 25 degrees. Thus, just because it is hot and sunny outside doesn’t mean it is safe to step out just yet.

Read more at https://www.merillife.com/blog/in-the-news/decrypting-covid19-all-we-know-about-the-novel-coronavirus-so-far

Meril creating Endless Possibilities at India Live 2020

Meril participated at 11th India Live 2020, Hotel Taj Palace, Delhi. The conference was attended by 1500 + national & international delegates. The faculty included top interventional cardiologists from across the globe who gathered under one roof to share their experience and knowledge.

6.2

The objective of the conference is to focus on “Interventional Cardiology: From Clinic to Cutting Edge”. You will have the opportunity to listen to and discuss cutting edge research with leading experts in various fields of Interventional Cardiology. Scientific committee is working hard to draw a comprehensive innovative program covering all major advances in the ever-expanding field of cardiovascular diseases. The meeting will feature live case demonstrations that will be performed by internationally renowned operators from India and abroad. Targeted informative and educational presentation on various contemporary topics was delivered by thought leaders during this four-day educational activity.

In addition to the scientific sessions, the industry will be encouraged to display latest devices and present their viewpoint. You will also have an opportunity to hone your skill on Simulators. It was indeed a much differentiated conference for Meril in many years of India live. In total 250+ HCPs from India and abroad visited Meril Learning & Innovation Hub, which provided a wide range of learning initiatives including TAVR Hands-on mentice simulation, 3Mensio & CT Analysis, Myval TAVR wet-model hands-on, Virtual reality (VR) immersive experience of Myval TAVR cases.

Master Class sessions at Meril Learning & Innovation Hub included 6 well attended and scientifically immersive lecture presentations on TAVR and Complex PCI by a host of key opinion leaders like Dr. G. Sengotuvellu, Dr A. Mullasari, Dr D.S. Gambhir, Dr. Siva Kumar, Dr. Vijay Kumar, Dr. Anmol Sonawane & Dr B. Starcevic. An interactive touchscreen allowed HCPs to explore Meril Cardiovascular’ s innovation journey over the years, learning along the way about our cutting edge products through digital brochures and videos.

Meril Evening Symposium on 29th Feb was attended by over 200 delegates, who heard senior interventional cardiologists like Dr Ashok Seth, Dr A. Mullasari, Dr. Rajneesh Kapoor and Dr. Enric Domingo speak about latest in DES, Bioresorbable therapy, furthering the TAVR therapy in India and beyond. The 3 day event came to a conclusion with delivering packed flavour of eye opening sessions on cardio therapies.

 

Headlines that make India proud through our strides in the field of med-tech and innovation

Cardiovascular disease is the leading cause of death in India since the 1990s. Over the last few decades, there have been multiple studies showing that the number of deaths caused by heart disease has only gone up since then. Recognising the need of the hour, Meril Life Sciences is the first Indian Medtech company to receive CE approval for the Myval Transcatheter Heart Valve and also for creating the world’s first 100 micron thin-strut bioresorbable vascular scaffold. As we continue to make headlines for these contributions to Medtech, let’s take a closer look at how our products reduce discomfort for patients and why we will continue making headlines that make our country proud.

What we did

A heart attack generally occurs when the flow of blood to your heart is blocked. This blockage is caused by a buildup of fat, cholesterol and other substances which form a clot inside your heart and disrupt blood flow. A popular method of treating this blockage is through the use of stents. A stent is a small mesh tube placed inside these blocked arteries. These stents then expand along with your aortic valve and help you restore regular blood flow. The drawback to this solution was that the stents available in the market were metallic stents, which, along with aiding recovery would also remain inside the heart as a permanent metal implant. Mr. Sanjeev Bhatt, Vice President Corporate Strategy, Meril Life Sciences, addressed this concern by explaining the MeRes 100 scaffold in further detail. He explained that the MeRes 100 uses a polymer with 100-micron thickness, which is almost half the width of a human hair. This ultra-thin scaffold is made from a polymer known as polylactide and is used to deliver drug-eluting stents that release medication to treat the blocked artery. This polymer not only releases medication into your arteries, they also fully degrade in 2-3 years, thus allowing the artery to heal naturally over time without further surgery.

How we did it

While the answer may seem simple now, 5 years ago, the question facing Dr. P.K Minocha, Director of Research at Meril Life Sciences looked as daunting as any. Is it possible to create a thinner strut stent, made of a polymer that degrades in three years, while still retaining the strength to fulfill its purpose of healing a blocked artery? To answer this question, the team working on the project ended up studying over 180 combinations of various polymers to narrow down their search to 12 desirable combinations. Work began by selecting one proprietary polymer blend as the material for this scaffold. Over 235,000 man-hours, coupled with millions of dollars of investment resulted in 18,000 prototypes, produced at various stages of development and bench testing. This is how they finally arrived at the now patented ultra-thin, bioresorbable stent.

The final obstacle

Even after the product had been created there was one final obstacle in the way, the safety and efficacy of this next-generation fully biodegradable scaffold had yet to be proven clinically. Various trials and clinical studies took place all across India, Brazil, Europe and Asia. Leading cardiologists from India and all across the world participated in these clinical studies. The first-year data from these studies showed zero scaffold thrombosis and virtually 100% strut coverage. These results stayed consistent over a testing period of about three years.

When we set out to create the next-generation biodegradable stent, which would benefit patients by strengthening their heart valve, the chances of success were slim. Apart from the wide array of medical devices which provide access to affordable and world-class healthcare for patients, the MeRes 100 and the Myval studies prove that Indian companies can not only produce world-class technology but can also innovate and advance patient care on a global scale. Staying true to our core tenet of adding more to life, Meril Life Sciences will continue to innovate and create new headlines to make India proud in the future.

Why we are India’s leading cardiac implant company and what drives us to continue innovating

We have all witnessed medical technology in the world around us. From vaccinations to the plasters worn to correct fractures to even spectacles that improve our eyesight. All of these were once new and revolutionary ideas that have stood the test of time and given us solutions to long-standing medical dilemmas. These advances in healthcare solutions are what led to long-term sustainable improvement in the quality of human life. We at Meril Life Sciences know that with changing times the need for better equipment and advanced medical devices will continue to increase. To create such devices that will soon be the need of the hour, we work tirelessly and continually seek excellence in the field of medicine.

In today’s world, the leading cause of death in India and the world at large, are cardiovascular diseases. A study conducted by The Lancet shows that the prevalence of stroke and heart disease in India has almost doubled in the past 25 years. Heart disease and strokes together contribute to about 28.1% of total deaths in our country today. Some of the factors that contribute to these rising numbers are: A rise in sedentary lifestyles, unhealthy diets, high cholesterol, type-2 diabetes, smoking habits, stressful lives, lack of sleep and many others. These factors have also led to a rise in coronary artery diseases in people from the age group of 25-35.

As the numbers show, heart disease is on the rise in all age groups and has now even begun to affect the youth. Meril understood the need for cardiovascular healthcare devices and began learning and innovating with stents and heart valve technology five years ago. Backed by clinical trials and reports from patients with over three years of use, Meril Life is proud to introduce the next generation fully bioresorbable vascular scaffold – MeRes100. With the ultra-thin 100-micron bioresorbable vascular scaffold, we created the world’s thinnest stent and paired it with a natural drug-eluting stent which degrades over time and allows the heart to resume normal function without requiring a stent.

This patented and indigenous technology created by India-based Meril Life Sciences has received both CDSCO & CE approval. Making it possible for us to provide the product to healthcare professionals all over the world. It has carved a niche for itself within the coronary stent space, especially in addressing the needs of a younger age group.

Meril Life Sciences is headquartered in India with a manpower of more than 4,000 employees, with the business currently being conducted in more than 100 countries. Our dedication towards research and development helps us chart a course to advanced healthcare solutions and is also reflected through our diverse range of products. Adhering to the highest quality standards in manufacturing, scientific communication and distribution, it is only natural that Meril Life Sciences is the leading cardiac implant company in India and will continue to strive for the same in the future.

Meril Life Sciences: Adding more to life

To an outsider, Meril Life Sciences is a young, India-based global medical device company. We design, innovate and provide medical devices to patients, doctors and distributors all over the world. And yet, simply digging deeper will show you real people, real lives and the core principles which paved the way to Meril Life Sciences becoming one of the leading medtech companies in the world. With a wide portfolio consisting of more than 140 products distributed across 100 plus countries, we deliver only the best and most advanced healthcare solutions. To get a better understanding of how we continue to innovate, inspire and tread new ground in the field of health and medicine, let us take a quick peek at some of our verticals.

Orthopaedics

Our journey into the field of orthopaedics began 10 years ago when we acquired Maxx Medical, an established US orthopaedic device company. With the expertise and support of world-renowned surgeons, we emerged as frontrunners in this segment, offering a diverse range of orthopaedic implants, from knee replacements to hip replacement to trauma along with revision portfolio. These devices are all developed using advanced design engineering technologies and extensive clinical experience to address the anatomical, physiological and lifestyle needs of today’s patients. These advanced designs and products allow our patients to achieve optimal high-flexion motion and restore their daily lives.

Vascular intervention

Our contributions to the global field of coronary artery diseases have already been discussed at length. Our team of talented and innovative engineers have created a varied range of devices such as drug-eluting stents, bioresorbable scaffolds, balloon catheters, peripheral vascular and transcatheter aortic valve replacement systems which help deal with coronary complications. These products are all backed by thorough clinical studies, patient feedback and a global team of scientific advisors. Our unique, top of the line medical devices are currently being used in over 100 countries worldwide.

Endosurgery

Meril Endosurgery is a one-stop solution for surgeons because of the extensive product portfolio we provide, comprising of absorbable & non-absorbable surgical sutures, tissue sealants, absorbable hemostats, intrauterine devices, energy devices and mechanical closure devices. These products, which are in use in more than 100 countries, are backed by a rich pipeline of products still undergoing research and development. Coupled with hands-on training sessions and surgical simulation services, the endosurgery vertical is an effective segment that provides patients with long term support and relief.

Along with the above three verticals, we also provide devices that aid diagnostics and ENT treatment. We believe that to deliver the latest and most-relevant medical equipment an ultra-modern manufacturing facility is a must. Our five verticals are all supported by a robust R&D foundry, responsible for the constant innovation and creation of better and more advanced healthcare devices. We at Meril Life Sciences exist to create best-in-class medical devices that help uplift the health of humankind and will continue to strive to reach this goal.

Create your website with WordPress.com
Get started